Caris Life Sciences, Inc. Common Stock
CAI
$31.98-0.90%
End of day · as of Sep 26, 2026, 9:15 AM ET
Mkt cap
$5.22B
EV/Sales
5.92
P/E ratio
N/A
FY2025 Revenue
$812.03M
EPS (FY2025)
$-0.41
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-8.38%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
Use this CAI research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CAI income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company in the Healthcare sector.
Latest cached Caris Life Sciences, Inc. Common Stock (CAI) revenue for Dec 31, 2025 was $812.0M. Net income was -$68.1M. Statements: https://lician.com/financials/cai
Caris Life Sciences, Inc. Common Stock (CAI) market capitalization is $5.22B on the latest cached snapshot.
Caris Life Sciences, Inc. Common Stock (CAI) cached previous close $32.27; day range $31.59 – $32.77; volume 2,909,417. Session quote: https://lician.com/quote/cai
Caris Life Sciences, Inc. Common Stock (CAI) latest cached earnings event is "CAI earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CAI filing is 8-K · Sep 14, 2026. Filings: https://lician.com/sec/cai